Global

Moderna seeks regulatory approval of RSV vaccine for people 60 and older - UPI.com Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States, European Union, Switzerland and Australia. UPI

...

Moderna said the regulatory applications come after positive data from a study of approximately 37,000 adults 60 or older in 22 countries. Its vaccine to protect from respiratory syncytial virus was found in these trials to be 83.7% effective as defined by two or more symptoms.

...

3 Vaccines for Fall: What You Need to Know Most Americans have had one or more shots of the flu and COVID-19 vaccines. New this year are the first shots to protect older adults from respiratory syncytial virus, a lesser-known threat whose toll in hospitalizations and deaths may rival that of flu. Federal health officials are hoping that widespread use of these three vaccines will head off another “tripledemic” of respiratory illnesses like the one seen last winter. For people with insurance, all of the vaccines should be available for fr Yahoo News

New York Times

WEDNESDAY, July 5, 2023 (HealthDay News) -- For much of the COVID-19 pandemic, doctors have told patients who get a negative result after taking a rapid antigen test at home to test again 48 hours later. ...

Whether you have symptoms or not, repeat testing after 48 hours may be required to rule out COVID infection, researchers from the University of Massachusetts Medical School found.

..

More kids diagnosed with type 1 diabetes during COVID-19 CIDRAP

More kids were diagnosed as having type 1 diabetes after the COVID-19 pandemic began, and researchers have yet to determine the mechanism behind this increased incidence rate, the authors of a new meta-analysis said in JAMA Network Open...